Ann: Trading Halt, page-215

MIPS will be the headquarters of the new ARC Training Centre for Cryo-Electron Microscopy of Membrane Proteins for Drug Discovery, established in collaboration with the University of Melbourne, University of Wollongong, the Walter and Eliza Hall Institute of Medical Research (WEHI) and industry partners including Catalyst Therapeutics, AstraZeneca, Pfizer, Dimerix Bioscience and Thermo Fisher Scientific.

The ITTC will provide new links between academic and commercial partners, providing increased opportunity for generation of new IP and expansion of economic investment into the Australian biotechnology sector. It will have a major focus on training industry-ready Higher Degree Research candidates and postdoctoral fellows



Thanks @afreak & BTB

This is really interesting & will our HIT-receptor platform play a role in this collaboration with some heavy hitters in drug discovery? We are really the only Australian biotech mentioned here.

Maybe we will get some news on this collaboration from Dimerix soon.

Have a great weekend all